Neuland Laboratories Limited announced the approval of its unaudited financial results for the quarter and half year ended September 30, 2026. The Board of Directors also approved a capital expenditure of ₹47.1 crore for the acquisition of a land parcel in Telangana, earmarked for future capacity expansion. The financial results show a mixed performance compared to the previous year’s comparable periods, with revenues fluctuating across reporting periods.
Financial Results and Capital Expenditure Approved
Neuland Laboratories Limited has announced the outcome of its Board of Directors’ meeting held on November 3, 2026. The Board considered and approved the unaudited financial results for the quarter and half year ended September 30, 2026, along with the limited review reports from the statutory auditors.
Strategic Land Acquisition
A significant decision made by the Board was the approval of a capital expenditure of ₹47.1 crore (including GST) for the acquisition of a land parcel measuring Ac.6-00 Gts situated at Domadugu Village, Sangareddy District, Telangana. This strategic acquisition is intended for future capacity expansion and will be financed through internal accruals.
Financial Highlights (Consolidated)
For the quarter ended September 30, 2026, the company reported total income of ₹45,715.22 lakhs and a profit before tax of ₹6,897.82 lakhs. Total comprehensive income for the quarter stood at ₹5,127.38 lakhs.
In the half-year ended September 30, 2026, total income was ₹1,10,722.10 lakhs, with profit before tax at ₹26,682.52 lakhs. The total comprehensive income for the half-year reached ₹19,885.79 lakhs.
The company also disclosed its segment reporting, indicating revenue from operations distributed across India, Europe, USA and North America, and the rest of the world. The primary reportable segment for the company remains the ‘manufacture of active pharmaceutical ingredients and allied services’.
The financial statements also provide details on assets and liabilities as of September 30, 2026, including property, plant and equipment, inventories, and financial assets and liabilities. The statement of cash flows highlights cash generated from operating, investing, and financing activities.
Source: BSE
